TRILEPTAL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug TRILEPTAL contains one active pharmaceutical ingredient (API):

1 Oxcarbazepine UNII VZI5B1W380 - OXCARBAZEPINE

The pharmacological activity of oxcarbazepine is primarily exerted through the metabolite (MHD). The mechanism of action of oxcarbazepine and MHD is thought to be mainly based on the blockade of voltage-sensitive sodium channels. Read about Oxcarbazepine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRILEPTAL Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AF02	Oxcarbazepine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8584T, 8585W, 8586X, 8588B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526515403119316, 526515404115314, 526515405111312, 526515408110317, 526515409117315, 526515410131415
Country: CA	Health Products and Food Branch	Identifier(s): 02242068, 02242069, 02244673
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.199-08-06, 27.284-10-06, 367430813
Country: EE	Ravimiamet	Identifier(s): 1009662, 1009673, 1009684, 1077230, 1077263, 1077274
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63093, 63095, 64398
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 422178, 552901, 556936, 556951
Country: FR	Base de données publique des médicaments	Identifier(s): 61556061, 64876757, 66064587, 69568788
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 140118, 146852, 146854, 146856, 162799, 162801, 186172, 36728, 369022, 369024, 374086, 37842, 381715, 38401, 394092, 73155
Country: HK	Department of Health Drug Office	Identifier(s): 49918, 50007, 50215
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-007294503, HR-H-061545230, HR-H-309957904
Country: IE	Health Products Regulatory Authority	Identifier(s): 29236, 37405, 44625, 49812, 49833, 49886, 74950, 74951
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002221, 1002223, 1014734
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 236M90, 362M94
Country: NL	Z-Index G-Standaard	Identifier(s): 14896214
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 56863, 56871, 70483
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8716, 8718, 8719, 9885
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100096439, 100096445, 100189744, 100232196, 100350122, 100355680, 100357822, 100375926, 100376009
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51416001, W51416002, W51416003, W51416004, W51416005, W51417001, W51417002, W51417003, W51417004, W51417005
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504090550, 8699504090604, 8699504700008
Country: US	FDA, National Drug Code	Identifier(s): 0078-0337, 0078-0357, 0078-0456, 0078-0457, 55289-007
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/2.5/0442, 36/2.5/0409, X/2.5/205, X/2.5/206